FEATURED CONTRIBUTED CONTENT

Waves of Real Life Data Are Inundating Pharma…Can They Keep Up?


Waves of Real Life Data Are Inundating Pharma…Can They Keep Up?

by Carlos Rodarte, Founder & Managing Director, Volar Health, LLC This is part one of a three-part series that will discuss how enhanced access to in-depth health data is impacting our understanding of personhood, the environment around us, and the pharma model. A New Understanding of Personhood Our understanding and perception of health and disease […]

June 8, 2018 More Clinical »
Patients as Partners: Imagining the Future of Rare Disease Therapies


Patients as Partners: Imagining the Future of Rare Disease Therapies

This is the first installment of our new webinar series, Healthy Opinions. It is now available to watch any time as an OnDemand resource. Healthy Opinions covers important topics in the life sciences industry. We feature top thought leaders and experts in a panel format. All panelists participate using their webcam. The focus of this […]

May 23, 2018 More Clinical »
Improving patient engagement through design psychology principles


Improving patient engagement through design psychology principles

For years, we’ve been hearing that digital health is the future, but so far, patient engagement has been low. Research on digital health interventions has generally found lack-luster usage and retention over time.  Yet we all know that successful evidence-based interventions that support better health, including medication adherence, lifestyle changes, and symptom management are very […]

April 24, 2018 More Clinical »
Enhance Precision Oncology Trial Success


Enhance Precision Oncology Trial Success

As the complexity of precision oncology trials increase, drug developers are facing the paradox of patient scarcity in the presence of data abundance. Using the right technologies can help to solve this paradox. Read our white paper to learn more.  

June 4, 2018 More Clinical »
Disruptive Innovation – The Impact Perspectives from Senior Pharma Executives


Disruptive Innovation – The Impact Perspectives from Senior Pharma Executives

What do you get when Senior Pharmaceutical Executives get together and brainstorm about disruptive innovation in the Life Sciences industry? You get some pretty interesting perspectives, and perhaps even a glimpse into the future. Early in 2018, ICON gathered a group of industry execs to discuss disruptive innovation, and how it could affect clinical trials […]

May 31, 2018 More Clinical »
Disruptive Innovation – The Impact Perspectives from Senior Pharma Executives


Disruptive Innovation – The Impact Perspectives from Senior Pharma Executives

Disruptive Innovation in the Life Science Industry At a panel session hosted by ICON early in 2018, senior executives from leading pharma companies shared their views on ‘Disruptive Innovation’. The session was chaired by Nuala Murphy (President, Clinical Research Services, ICON) and guest panellists Francesca Wuttke (Managing Director, MSD Global Health Innovation Fund), Dr. William H. Carson (President and CEO of Otsuka […]

May 25, 2018 More Clinical »
Better understanding where and how we live will vastly improve remote patient monitoring approaches


Better understanding where and how we live will vastly improve remote patient monitoring approaches

by Carlos Rodarte, Founder & Managing Director, Volar Health, LLC This is part two of a three-part series that discusses how enhanced access to in-depth health data is impacting our understanding of personhood, the environment around us, and the pharma model. Our Environment, Decoded Depending on who you are speaking with, the word “environment” may […]

June 20, 2018 More Clinical »
FEEDBACK